{"id":"https://openalex.org/W4308255402","doi":"https://doi.org/10.1007/s00277-022-05014-3","title":"Impact of tablet crushing on the dissolution of venetoclax","display_name":"Impact of tablet crushing on the dissolution of venetoclax","publication_year":2022,"publication_date":"2022-11-04","ids":{"openalex":"https://openalex.org/W4308255402","doi":"https://doi.org/10.1007/s00277-022-05014-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/36333488"},"language":"en","primary_location":{"id":"doi:10.1007/s00277-022-05014-3","doi":"https://doi.org/10.1007/s00277-022-05014-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00277-022-05014-3","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056888898","display_name":"Takeo Yasu","orcid":"https://orcid.org/0000-0003-0587-0091","observed_orcids":["https://orcid.org/0000-0003-0587-0091"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]},{"id":"https://openalex.org/I4210103327","display_name":"Tokyo Metropolitan Bokutoh Hospital","ror":"https://ror.org/01dk3f134","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210103327"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takeo Yasu","raw_affiliation_strings":["Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan. yasutakeo-tky@umin.ac.jp","Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan. yasutakeo-tky@umin.ac.jp","Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan. yasutakeo-tky@umin.ac.jp","Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Kiyose, Japan","Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan"],"raw_orcid":"https://orcid.org/0000-0003-0587-0091","affiliations":[{"raw_affiliation_string":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan. yasutakeo-tky@umin.ac.jp","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan. yasutakeo-tky@umin.ac.jp","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan. yasutakeo-tky@umin.ac.jp","institution_ids":["https://openalex.org/I4210103327"]},{"raw_affiliation_string":"Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Kiyose, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan","institution_ids":["https://openalex.org/I4210103327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076744308","display_name":"Eri Hikita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103327","display_name":"Tokyo Metropolitan Bokutoh Hospital","ror":"https://ror.org/01dk3f134","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210103327"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eri Hikita","raw_affiliation_strings":["Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","institution_ids":["https://openalex.org/I4210103327"]},{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan","institution_ids":["https://openalex.org/I4210103327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042290219","display_name":"Yoshito Gando","orcid":"https://orcid.org/0000-0002-8826-2296","observed_orcids":["https://orcid.org/0000-0002-8826-2296"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshito Gando","raw_affiliation_strings":["Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Kiyose, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Kiyose, Japan","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062653078","display_name":"Moyumi Odate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Moyumi Odate","raw_affiliation_strings":["Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, Kiyose, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, Kiyose, Japan","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021857641","display_name":"Motoki Inoue","orcid":"https://orcid.org/0000-0001-5673-5290","observed_orcids":["https://orcid.org/0000-0001-5673-5290","https://orcid.org/0009-0008-0248-5167"]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Motoki Inoue","raw_affiliation_strings":["Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, Kiyose, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo, 204-8588, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University, Kiyose, Japan","institution_ids":["https://openalex.org/I23172683"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065350282","display_name":"Mikio Shirota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23172683","display_name":"Meiji Pharmaceutical University","ror":"https://ror.org/00wm7p047","country_code":"JP","type":"education","lineage":["https://openalex.org/I23172683"]},{"id":"https://openalex.org/I4210103327","display_name":"Tokyo Metropolitan Bokutoh Hospital","ror":"https://ror.org/01dk3f134","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210103327"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikio Shirota","raw_affiliation_strings":["Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Sumida-Ku, Japan","Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Koutoubashi, Sumida-Ku, Tokyo, 130-8575, Japan","institution_ids":["https://openalex.org/I4210103327"]},{"raw_affiliation_string":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Sumida-Ku, Japan","institution_ids":["https://openalex.org/I23172683"]},{"raw_affiliation_string":"Department of Pharmacy, Tokyo Metropolitan Bokutoh Hospital, Sumida-Ku, Japan","institution_ids":["https://openalex.org/I4210103327"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056888898"],"corresponding_institution_ids":["https://openalex.org/I23172683","https://openalex.org/I4210103327"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.3554,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.54031276,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"102","issue":"1","first_page":"219","last_page":"220"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.6909000277519226,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.6909000277519226,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.14419999718666077,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.029999999329447746,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tablet-crushing","display_name":"tablet crushing","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-dissolution","display_name":"drug dissolution","score":0.8830000162124634},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.5550000071525574},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.6150000095367432},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9456696510314941},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.6160814762115479},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5168136358261108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4878733158111572},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.325890451669693},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.14631029963493347},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00277-022-05014-3","doi":"https://doi.org/10.1007/s00277-022-05014-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00277-022-05014-3","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},{"id":"pmid:36333488","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36333488","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of hematology","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2121960517","https://openalex.org/W2767999118","https://openalex.org/W2989709087","https://openalex.org/W4226180487","https://openalex.org/W4281555424"],"related_works":["https://openalex.org/W2053623051","https://openalex.org/W3039144888","https://openalex.org/W2412940593","https://openalex.org/W3088105037","https://openalex.org/W4205963513","https://openalex.org/W2406075569","https://openalex.org/W2515097514","https://openalex.org/W2403922689","https://openalex.org/W3173133760","https://openalex.org/W2026230256"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2022-11-09T00:00:00"}